INSPIRATION HEALTHCARE GROUP PLC

Board/Management Information • Jun 26, 2020

National Storage Mechanism | Additional information

RNS Number : 1466R

Inspiration Healthcare Group PLC

26 June 2020

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Appointment of CFO

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, is pleased to announce the appointment of Jonathan (Jon) Ballard as the Group's Chief Financial Officer and Company Secretary with effect from 1 July 2020.

Jon joined Inspiration Healthcare in 2017 as Group Finance Controller and has worked alongside Mike Briant the retiring Chief Financial Officer for over 3 years. As has been previously announced, Mike Briant will retire from the Board at the end of June 2020 and will continue to work full time with the Group until the end of August and will then continue during a handover period part time until November 2020.

In accordance with Rule 17 and Schedule Two (g) of the AIM Rules the following information in relation to the appointment of Jon Ballard  is disclosed:

Jon, aged 42, does not hold and has not held directorships/partnerships in the five years preceding his appointment at the Company. 

Jon does not currently hold any Ordinary Shares in the Company.

Enquiries:

Inspiration Healthcare Group plc Neil Campbell, Chief Executive Officer Mike Briant, Chief Financial Officer Jon Ballard, Financial Controller	Tel: 01455 840555
Nominated Adviser & Broker Cenkos Securities plc Mark Connelly Stephen Keys Cameron MacRitchie	Tel: 0207 397 8900
Cadogan PR Alex Walters alex.walters@cadoganpr.com	Tel: 07771 713608

About Inspiration Healthcare http://www.inspiration-healthcare.com

Inspiration Healthcare is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.

Through investment in research and development the Company has 6 key own brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally the Company has its own range of products for maintaining normothermia pre- during and post-surgery.

With product availability extending to over 50 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe. In the UK and Ireland the Company has a direct sales team selling Inspiration Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance. Further information on Inspiration Healthcare can be seen at: www.inspiration-healthcare.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCBIGDLXBDDGGU